Effect of Prophylactic Aqueous Suppression on Hyperencapsulation of Ahmed Glaucoma Valves
Status:
Unknown status
Trial end date:
2020-06-01
Target enrollment:
Participant gender:
Summary
After implantation of an Ahmed glaucoma valve in patients with glaucoma, hyperencapsulation
phase is an unwanted postoperative phenomenon, typically occurring with the free 3 months
postoperatively. When this does occur, it is treated with aqueous suppressant eye drops.
This study aims to determine if it is possible to reduce the rate of hyperencapsulation
phase. Patients in the treatment group will receive aqueous suppressant eye drops before the
hyperencapsulation phase starts. Treatment will be initiated once their intraocular pressure
is above a pre-defined level, and will target a pre-defined range.